{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:36:05Z","timestamp":1780050965175,"version":"3.53.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","award":["PGSG # 48870"],"award-info":[{"award-number":["PGSG # 48870"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116580","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:08:13Z","timestamp":1774930093000},"page":"116580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enzymatically-modified isoquercitrin alleviates skin inflammation, mast cell degranulation, and vascular hyperpermeability in a mouse model of plaque psoriasis"],"prefix":"10.1016","volume":"178","author":[{"given":"Gehan","family":"Waheed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116580_bb0005","doi-asserted-by":"crossref","unstructured":"G. Damiani, N.L. Bragazzi, C. Karimkhani Aksut, D. Wu, G. Alicandro, D. McGonagle, C. Guo, R. Dellavalle, A. Grada, P. Wong, C. La Vecchia, L.S. Tam, K.D. Cooper, M. Naghavi, The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study, Front. Med. (Lausanne) 8 (2021) 743180, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34977058.","DOI":"10.3389\/fmed.2021.743180"},{"issue":"6","key":"10.1016\/j.intimp.2026.116580_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/2229-5178.193908","article-title":"General measures and quality of life issues in psoriasis","volume":"7","author":"Sarkar","year":"2016","journal-title":"Indian Dermatol. Online J."},{"issue":"2","key":"10.1016\/j.intimp.2026.116580_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2026.116580_bb0020","first-page":"7","article-title":"Current knowledge on psoriasis and autoimmune diseases","volume":"6","author":"Ayala-Fontanez","year":"2016","journal-title":"Psoriasis (Auckl)"},{"issue":"18","key":"10.1016\/j.intimp.2026.116580_bb0025","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116580_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116580_bb0035","doi-asserted-by":"crossref","unstructured":"D. Samotij, B. Nedoszytko, J. Bartosinska, A. Batycka-Baran, R. Czajkowski, I.T. Dobrucki, L.W. Dobrucki, M. Gorecka-Sokolowska, A. Janaszak-Jasienicka, D. Krasowska, L. Kalinowski, M. Macieja-Stawczyk, R.J. Nowicki, A. Owczarczyk-Saczonek, A. Ploska, D. Purzycka-Bohdan, A. Radulska, E. Reszka, A. Siekierzycka, A. Slominski, R. Slominski, M. Sobalska-Kwapis, D. Strapagiel, A. Szczerkowska-Dobosz, J. Szczech, M. Zmijewski, A. Reich, Pathogenesis of psoriasis in the \"omic\" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances, Postepy Dermatol Alergol 37(2) (2020) 135\u2013153, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32489346.","DOI":"10.5114\/ada.2020.94832"},{"key":"10.1016\/j.intimp.2026.116580_bb0040","doi-asserted-by":"crossref","unstructured":"H. Ben Abdallah, C. Johansen, L. Iversen, Key signaling pathways in psoriasis: recent insights from antipsoriatic therapeutics, Psoriasis (Auckl) 11 (2021) 83\u201397, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34235053.","DOI":"10.2147\/PTT.S294173"},{"issue":"13","key":"10.1016\/j.intimp.2026.116580_bb0045","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.3390\/ijms22136740","article-title":"From messengers to receptors in psoriasis: the role of IL-17RA in disease and treatment","volume":"22","author":"Vidal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116580_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2026.116580_bb0055","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.3390\/ijms22094589","article-title":"Mast cells in the skin: defenders of integrity or offenders in inflammation?","volume":"22","author":"Voss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116580_bb0060","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116580_bb0065","doi-asserted-by":"crossref","unstructured":"A. Motolese, M. Ceccarelli, L. Macca, F. Li Pomi, Y. Ingrasciotta, G. Nunnari, C. Guarneri, Novel therapeutic approaches to psoriasis and risk of infectious disease, Biomedicines 10 (2) (2022) 228, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35203438.","DOI":"10.3390\/biomedicines10020228"},{"key":"10.1016\/j.intimp.2026.116580_bb0070","doi-asserted-by":"crossref","first-page":"1349636","DOI":"10.3389\/fimmu.2024.1349636","article-title":"Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data","volume":"15","author":"Ding","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116580_bb0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14656566.2024.2373354","article-title":"Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond","volume":"25","author":"Portarapillo","year":"2024","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.intimp.2026.116580_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2016.02.001","article-title":"Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model","volume":"33","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116580_bb0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","article-title":"Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway","volume":"48","author":"Chen","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116580_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176823","article-title":"PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-\u03baB and production of inflammatory cytokines","volume":"12","author":"Dou","year":"2017","journal-title":"PloS One"},{"issue":"19","key":"10.1016\/j.intimp.2026.116580_bb0095","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.3390\/molecules26196086","article-title":"Cudraxanthone D ameliorates psoriasis-like skin inflammation in an imiquimod-induced mouse model via inhibiting the inflammatory signaling pathways","volume":"26","author":"Kim","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.116580_bb0100","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.intimp.2021.107754","article-title":"Galangin ameliorates imiquimod-induced psoriasis-like skin inflammation in BALB\/c mice via down regulating NF-\u03baB and activation of Nrf2 signaling pathways","author":"Sangaraju","year":"2021","journal-title":"Int. Immunopharmacol. 96"},{"issue":"4","key":"10.1016\/j.intimp.2026.116580_bb0105","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/ijms23042112","article-title":"Selenium-rich yeast peptide fraction ameliorates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting inflammation via MAPK and NF-\u03baB signaling pathways","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15569527.2021.2003377","article-title":"Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects","volume":"41","author":"Mousa","year":"2022","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00403-024-03565-1","article-title":"Topical formulation of Boswellia nano emulsion in psoriasis mouse model","volume":"317","author":"Fereidouni","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.intimp.2026.116580_bb0120","doi-asserted-by":"crossref","first-page":"156379","DOI":"10.1016\/j.phymed.2025.156379","article-title":"Exploring the therapeutic potential of Abelmoschi Corolla in psoriasis: mechanisms of action and inflammatory pathway disruption","volume":"138","author":"Qu","year":"2025","journal-title":"Phytomedicine"},{"issue":"20","key":"10.1016\/j.intimp.2026.116580_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-7847.194044","article-title":"Overviews of biological importance of quercetin: a bioactive flavonoid","volume":"10","author":"Anand David","year":"2016","journal-title":"Pharmacogn. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2010.06.036","article-title":"Alpha-oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans","volume":"501","author":"Murota","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2026.116580_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcp.2017.03.021","article-title":"Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function","volume":"139","author":"Terao","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116580_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107735","article-title":"Sodium R-lipoate and enzymatically-modified isoquercitrin suppressed IgE-independent anaphylactic reactions and stress-induced gastric ulceration in mice","volume":"97","author":"Waheed","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116580_bb0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/08820139.2024.2401551","article-title":"Potential antiallergic activity of two chemically\/enzymatically-modified natural products against active atopic and systemic anaphylaxes in CD1 mice models","volume":"53","author":"Ramadan","year":"2024","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2026.116580_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105676","article-title":"Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis","volume":"74","author":"Hou","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116580_bb0155","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/php.13919","article-title":"Protective effect of isoquercitrin on UVB-induced injury in HaCaT cells and mice skin through anti-inflammatory, antioxidant, and regulation of MAPK and JAK2-STAT3 pathways","volume":"100","author":"Li","year":"2024","journal-title":"Photochem. Photobiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116580_bb0160","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1007\/s00210-024-03722-3","article-title":"Quercetin as a therapeutic agent for skin problems: a systematic review and meta-analysis on antioxidant effects, oxidative stress, inflammation, wound healing, hyperpigmentation, aging, and skin cancer","volume":"398","author":"Okselni","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116580_bb0165","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s10753-025-02236-1","article-title":"Topical anti-inflammatory effects of quercetin glycosides on atopic dermatitis-like lesions: influence of the glycone type on efficacy and skin absorption","volume":"48","author":"Yang","year":"2025","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.intimp.2026.116580_bb0170","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116580_bb0175","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116580_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S2221-1691(12)60021-5","article-title":"Screening of flavonoid \u201cquercetin\u201d from the rhizome of Smilax china Linn. for anti-psoriatic activity","volume":"2","author":"Vijayalakshmi","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.intimp.2026.116580_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jff.2017.08.034","article-title":"Quercitrin extracted from Tartary buckwheat alleviates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting the Th17 cell response","volume":"38","author":"Chen","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.intimp.2026.116580_bb0190","doi-asserted-by":"crossref","first-page":"558629","DOI":"10.3389\/fphar.2020.558629","article-title":"Serum metabolomic profiling reveals the amelioration effect of methotrexate on imiquimod-induced psoriasis in mouse","volume":"11","author":"Zong","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2026.116580_bb0195","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1177\/1535370216647183","article-title":"Original research: different imiquimod creams resulting in differential effects for imiquimod-induced psoriatic mouse models","volume":"241","author":"Luo","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2026.116580_bb0200","doi-asserted-by":"crossref","first-page":"773280","DOI":"10.3389\/fimmu.2021.773280","article-title":"Immune cell infiltration analysis demonstrates excessive mast cell activation in psoriasis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116580_bb0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rvsc.2018.01.016","article-title":"Activation of mast cells in skin abscess induced by Staphylococcus aureus (S. aureus) infection in mice","volume":"118","author":"Lei","year":"2018","journal-title":"Res. Vet. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.116580_bb0210","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4103\/jomfp.JOMFP_267_19","article-title":"Quantification of mast cells in nonreactive and reactive lesions of gingiva: a comparative study using toluidine blue and immunohistochemical marker mast cell tryptase","volume":"25","author":"Jain","year":"2021","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"10.1016\/j.intimp.2026.116580_bb0215","article-title":"Measuring local anaphylaxis in mice","volume":"92","author":"Evans","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2026.116580_bb0220","series-title":"Introduction to Analysis of Variance: Design, Analysis & Interpretation, SAGE, Thousand Oaks","author":"Turner","year":"2001"},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2026.116580_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jdv.17053","article-title":"Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis","volume":"35","author":"Lebwohl","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116580_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15104","article-title":"Emerging paradigm shift toward proactive topical treatment of psoriasis: a narrative review","volume":"34","author":"Papp","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1346-8138.17968","article-title":"Prospective, open-label, multicenter study of apremilast as maintenance therapy for psoriasis patients in remission with biologics","volume":"53","author":"Kamiya","year":"2026","journal-title":"J. Dermatol."},{"key":"10.1016\/j.intimp.2026.116580_bb0240","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.fct.2016.09.030","article-title":"Ninety-day toxicity and single-dose toxicokinetics study of alpha-glycosyl isoquercitrin in Sprague-Dawley rats","volume":"97","author":"Nyska","year":"2016","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12970-019-0303-x","article-title":"Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial","volume":"16","author":"Omi","year":"2019","journal-title":"J. Int. Soc. Sports Nutr."},{"issue":"23","key":"10.1016\/j.intimp.2026.116580_bb0250","doi-asserted-by":"crossref","first-page":"14784","DOI":"10.3390\/ijms232314784","article-title":"Enzymatically modified isoquercitrin: production, metabolism, bioavailability, toxicity, pharmacology, and related molecular mechanisms","volume":"23","author":"Owczarek-Januszkiewicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.116580_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/S0007114519002137","article-title":"Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease","volume":"123","author":"Bondonno","year":"2020","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.intimp.2026.116580_bb0260","doi-asserted-by":"crossref","first-page":"167879","DOI":"10.1016\/j.bbadis.2025.167879","article-title":"Quercetin induces keratinocytes apoptosis via triple inhibition of Notch, PI3K\/AKT signaling and Glut1 in the treatment of psoriasis","volume":"1871","author":"Chen","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0265","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1038\/s41598-019-39903-x","article-title":"Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice","volume":"9","author":"Horvath","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2026.116580_bb0270","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/jid.2011.72","article-title":"The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration","volume":"131","author":"Gschwandtner","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2026.116580_bb0275","doi-asserted-by":"crossref","first-page":"2249834","DOI":"10.1155\/2022\/2249834","article-title":"Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches","volume":"2022","author":"Medovic","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"20","key":"10.1016\/j.intimp.2026.116580_bb0280","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.3390\/ijms232012137","article-title":"Impact of ROS-dependent lipid metabolism on psoriasis pathophysiology","volume":"23","author":"Wronski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.116580_bb0285","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3390\/antiox13101222","article-title":"Unraveling mitochondrial reactive oxygen species involvement in psoriasis: the promise of antioxidant therapies","volume":"13","author":"Ahmad Jamil","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.116580_bb0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.14530","article-title":"Prostaglandin-cytokine crosstalk in chronic inflammation","volume":"176","author":"Yao","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116580_bb0295","first-page":"38","article-title":"The serum level of oxidative stress and antioxidant markers in patients with psoriasis: a cross-sectional study","volume":"14","author":"Shakoei","year":"2021","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0300","doi-asserted-by":"crossref","first-page":"20712","DOI":"10.1038\/s41598-025-08451-y","article-title":"Rutin ameliorates imiquimod-induced psoriasis-like skin lesions by inhibiting oxidative stress injury and the inflammatory response in mice via the Keap1\/Nrf2 signaling pathway","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.intimp.2026.116580_bb0305","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2660","article-title":"Mouse model of immune complex-mediated vasculitis in dorsal skin and assessment of the neutrophil-mediated tissue damage","volume":"7","author":"Jiang","year":"2017","journal-title":"Bio-Protoc."},{"issue":"1","key":"10.1016\/j.intimp.2026.116580_bb0310","first-page":"101","article-title":"Expression of skin barrier protein filaggrin in skin diseases without atopic dermatitis","volume":"6","author":"Zhang","year":"2018","journal-title":"J. Biosci. Med. (Irvine)"},{"issue":"4","key":"10.1016\/j.intimp.2026.116580_bb0315","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jid.2020.07.028","article-title":"Neutrophils enhance cutaneous vascular dilation and permeability to aggravate psoriasis by releasing matrix metallopeptidase 9","volume":"141","author":"Chen","year":"2021","journal-title":"J. Invest. Dermatol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116580_bb0320","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1182\/blood-2011-07-358432","article-title":"Mast cell modulation of the vascular and lymphatic endothelium","volume":"118","author":"Kunder","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2026.116580_bb0325","first-page":"106","article-title":"Vascular permeability and Evans blue dye: a physiological and pharmacological approach","volume":"4","author":"Nidavani","year":"2014","journal-title":"J. Appl. Pharm. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:23:34Z","timestamp":1776129814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"alternative-id":["S156757692600425X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116580","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzymatically-modified isoquercitrin alleviates skin inflammation, mast cell degranulation, and vascular hyperpermeability in a mouse model of plaque psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116580"}}